SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-059755
Filing Date
2023-11-07
Accepted
2023-11-07 07:05:30
Documents
77
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fulc-20230930.htm   iXBRL 10-Q 2840238
2 EX-10.1 fulc-ex10_1.htm EX-10.1 546645
3 EX-10.2 fulc-ex10_2.htm EX-10.2 149882
4 EX-31.1 fulc-ex31_1.htm EX-31.1 13772
5 EX-31.2 fulc-ex31_2.htm EX-31.2 13763
6 EX-32.1 fulc-ex32_1.htm EX-32.1 7498
7 EX-32.2 fulc-ex32_2.htm EX-32.2 6986
  Complete submission text file 0000950170-23-059755.txt   10479287

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fulc-20230930_lab.xml EX-101.LAB 480468
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fulc-20230930_pre.xml EX-101.PRE 384879
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fulc-20230930.xsd EX-101.SCH 63368
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fulc-20230930_def.xml EX-101.DEF 252872
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fulc-20230930_cal.xml EX-101.CAL 45637
71 EXTRACTED XBRL INSTANCE DOCUMENT fulc-20230930_htm.xml XML 1742449
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Filer) CIK: 0001680581 (see all company filings)

IRS No.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38978 | Film No.: 231381517
SIC: 2834 Pharmaceutical Preparations